Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

Fig. 1

Correlation between baseline BLyS mRNA levels and baseline IFN-1 levels. One patient did not receive a dose of study medication but is included here as his/her baseline gene expression sample was analysed. BLyS B lymphocyte stimulator, CI confidence interval, CT cycle threshold, IFN interferon, IFN-1 type 1 IFN-inducible gene signature, mRNA messenger ribonucleic acid

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us